Date(s) - 05/16/2017 - 05/19/2017
Palais Des Congrès de Paris
NAMSA, the world’s only Medical Research Organization (MRO) with extensive regulatory, preclinical and clinical experience in cardiovascular medical devices, will participate in the upcoming EuroPCR Confernece, the official Congress of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), on May 16 – 19 in Paris, France, at the Palais des Congrès.
NAMSA’s cardiovascular preclinical experts Céline Furne (Medical Research Manager) and Dr. Jean-Pierre Boutrand (Vice President of U.S. Lab Services) will be available at the congress to meet with you to discuss the challenges your device program may be facing, or to answer any questions you may have pertaining to medical device development.
To sign up for your free one-hour consultation with Mrs. Furne (on May 17) or Dr. Boutrand (on May 18 – 19), to learn more about how you can accelerate your preclinical research and market access, please fill out the form below to reserve your spot.
To read more about NAMSA’s experience within the global cardiovascular marketplace, we invite you to read our information sheet which provides an overview of our extensive experience within this unique therapeutic area.
Online reservations are not available for this event.